A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
This study has been terminated.
Sponsor:
Seattle Genetics, Inc.
Collaborator:
Genentech
Information provided by (Responsible Party):
Seattle Genetics, Inc.
ClinicalTrials.gov Identifier:
NCT00529503
First received: September 11, 2007
Last updated: October 7, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | May 2011 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | June 16, 2011 |